Indication
Vomiting
14 clinical trials
21 products
3 drugs
Clinical trial
A Randomized, Double-Blind, Placebo- and Active-Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg (Hydrocodone 5 mg/Acetaminophen 325 mg/Promethazine 12.5 mg) as a Treatment for Moderate-to-Severe Acute Pain and the Prevention of Opioid-Induced Nausea and Vomiting (OINV) Following Orthopedic SurgeryStatus: Completed, Estimated PCD: 2018-04-16
Product
NorcoProduct
PlaceboProduct
CL-108Clinical trial
Pharmacokinetic and Pharmacodynamic Evaluation of 3 Standard Formulations of Δ9-THC in Healthy Volunteers and Post-chemotherapy Patients in ColombiaStatus: Not yet recruiting, Estimated PCD: 2024-02-15
Product
THC oral formulationsClinical trial
Protreat-Trial: Prophylactic Antiemetic Treatment of Opioid-induced Nausea and Vomiting (OINV) in Palliative Care: A Randomized Controlled Phase II Feasibility TrialStatus: Recruiting, Estimated PCD: 2024-05-01
Product
PalonosetronClinical trial
Evaluating the Use of Enhanced Recovery Strategies and Paravertebral Block in Elective Breast Reduction and Breast AugmentationStatus: , Estimated PCD: 2026-04-01
Product
Paravertebral blockClinical trial
Antiemetic Fosaprepitant To Remedy Nausea and VomitingStatus: Not yet recruiting, Estimated PCD: 2024-12-01
Product
FosaprepitantProduct
OndansetronClinical trial
Aprepitant- and Olanzapine- Containing Regimens for Prevention of Acute and Delayed Nausea and Vomiting Associated With High Dose Melphalan and BEAM in Autologous Stem Cell Transplant PatientsStatus: Completed, Estimated PCD: 2021-12-30
Product
AprepitantProduct
OlanzapineProduct
Aprepitant + OlanzapineClinical trial
Fixed-Dose Netupitant and Palonosetron for Chronic Nausea and Vomiting in Cancer PatientsStatus: Completed, Estimated PCD: 2022-02-14
Product
NetupitantDrug
PalonosetronClinical trial
Multi-dose Oral Ondansetron For Pediatric Gastroenteritis: A Pragmatic Randomized Controlled TrialStatus: Recruiting, Estimated PCD: 2024-06-01
Product
Oral PlaceboClinical trial
The Effectiveness of Small Doses of Ketamine With Morphine on Decreasing Pain Responses During Open Wound CareStatus: Completed, Estimated PCD: 2009-04-01
Product
Morphine + KetamineProduct
MorphineClinical trial
Value of Ondansetron Medication vs Inhaled Isopropyl Therapy in the Emergency Department (VOMIITED)Status: Completed, Estimated PCD: 2023-03-01
Product
ZofranClinical trial
Randomized Controlled Trial of Olanzapine for the Control of Chemotherapy-induced Vomiting in Children Receiving Highly Emetogenic ChemotherapyStatus: Recruiting, Estimated PCD: 2025-03-01
Drug
OlanzapineClinical trial
A Single Center, Randomized Controlled Prospective Double-blinded Trial Comparing Haloperidol to Standard Ondansetron Therapy for Control of Nausea and Vomiting in the Emergency DepartmentStatus: Completed, Estimated PCD: 2023-05-22
Product
HaloperidolClinical trial
Hyoscine Butyl-bromide Versus Ondansetron for Nausea and Vomiting During Cesarean Section Under Spinal Anesthesia: A Randomized Clinical TrialStatus: Completed, Estimated PCD: 2022-12-12
Product
Hyoscine N ButylbromideDrug
VarlilumabClinical trial
Intraoperative Autonomic Neural Blockade (ANB) Comparison Between Different Local Anesthetic Combinations. A Randomized Clinical Trial ProtocolStatus: Not yet recruiting, Estimated PCD: 2024-04-02
Product
Bupivacaine + DexamethasoneProduct
Bupivacaine + Clonidine